Physicians and pharmaceutical companies involved in clinical trials with patients with hematological diseases should be aware of these problems and make efforts to attenuate the socioeconomic burden of participation in the trials.

Socioeconomic burden of participation in clinical trials in patients with myeloproliferative neoplasms / Goel, Swati; Paoli, Chiara; Iurlo, Alessandra; Pereira, Arturo; Efficace, Fabio; Barbui, Tiziano; Tefferi, Ayalew; Vannucchi, Alessandro M.; Cervantes, Francisco. - In: EUROPEAN JOURNAL OF HAEMATOLOGY. - ISSN 0902-4441. - ELETTRONICO. - (2017), pp. 1-6. [10.1111/ejh.12887]

Socioeconomic burden of participation in clinical trials in patients with myeloproliferative neoplasms

PAOLI, CHIARA;VANNUCCHI, ALESSANDRO MARIA;
2017

Abstract

Physicians and pharmaceutical companies involved in clinical trials with patients with hematological diseases should be aware of these problems and make efforts to attenuate the socioeconomic burden of participation in the trials.
2017
1
6
Goal 3: Good health and well-being for people
Goel, Swati; Paoli, Chiara; Iurlo, Alessandra; Pereira, Arturo; Efficace, Fabio; Barbui, Tiziano; Tefferi, Ayalew; Vannucchi, Alessandro M.; Cervantes...espandi
File in questo prodotto:
File Dimensione Formato  
Goel_et_al-2017-European_Journal_of_Haematology.pdf

Accesso chiuso

Tipologia: Pdf editoriale (Version of record)
Licenza: Tutti i diritti riservati
Dimensione 284.02 kB
Formato Adobe PDF
284.02 kB Adobe PDF   Richiedi una copia

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1083665
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 5
social impact